Cargando…

Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming

Glioblastoma (GBM) is the most aggressive malignant primary brain tumour in adulthood. Despite strong research efforts current treatment options have a limited impact on glioma stem-like cells (GSCs) which contribute to GBM formation, progression and chemoresistance. Invasive growth of GSCs is in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsiampali, Julia, Neumann, Silke, Giesen, Beatriz, Koch, Katharina, Maciaczyk, Donata, Janiak, Christoph, Hänggi, Daniel, Maciaczyk, Jaroslaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698190/ https://www.ncbi.nlm.nih.gov/pubmed/33187081 http://dx.doi.org/10.3390/ph13110378

Ejemplares similares

Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
por: Koch, Katharina, et al.
Publicado: (2016)

A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
por: Koch, Katharina, et al.
Publicado: (2020)

Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells
por: Aretz, Philippe, et al.
Publicado: (2022)

Characterization of a Setup to test the Impact of High-Amplitude Pressure Waves on Living Cells
por: Schmidt, Mischa, et al.
Publicado: (2014)

Should Deep Brain Stimulation Programs Be Halted During the COVID-19 Pandemic? Balancing the Risk of COVID-19 Infection Against the Survival Benefits of DBS
por: Bara, Gregor A., et al.
Publicado: (2020)

A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome
por: Bara, Gregor A., et al.
Publicado: (2020)

p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming
por: Martin-Lopez, Marta, et al.
Publicado: (2017)

A microsurgical procedure for middle cerebral artery occlusion by intraluminal monofilament insertion technique in the rat: a special emphasis on the methodology
por: Güzel, Aslan, et al.
Publicado: (2014)

Epigenetic reprogramming in the epithelial-to-mesenchymal transition
por: Hoang, Stephen, et al.
Publicado: (2012)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells
por: Yusuf, Suad, et al.
Publicado: (2022)

Editorial to Special Issue “Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective”
por: Sharma, Amit, et al.
Publicado: (2023)

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019)

Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)
por: Bao, Yong xing, et al.
Publicado: (2013)

CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
por: Lupia, Michela, et al.
Publicado: (2018)

Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition
por: McDonald, Oliver G., et al.
Publicado: (2011)

The Epithelial-Mesenchymal Transition Factor SNAIL Paradoxically Enhances Reprogramming
por: Unternaehrer, Juli J., et al.
Publicado: (2014)

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
por: Maciaczyk, D, et al.
Publicado: (2017)

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022)

Marginalizing the genomic architecture to identify crosstalk across cancer and neurodegeneration
por: Sharma, Amit, et al.
Publicado: (2023)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2019)

Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain
por: Sharma, Amit, et al.
Publicado: (2023)

Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition
por: Hua, Wan, et al.
Publicado: (2021)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
por: Suwala, Abigail Kora, et al.
Publicado: (2018)

Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
por: Malouf, Gabriel G, et al.
Publicado: (2013)

Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism
por: Aspuria, Paul-Joseph P, et al.
Publicado: (2014)

Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
por: Jiang, Lei, et al.
Publicado: (2014)

Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells
por: Takaishi, Mikiro, et al.
Publicado: (2016)

Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2020)

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
por: Hua, Wan, et al.
Publicado: (2019)

Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells
por: Daniel, Yoann, et al.
Publicado: (2021)

Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer
por: Galbraith, Madeline, et al.
Publicado: (2022)

Patient Safety Comparison of Frameless and Frame-Based Stereotactic Navigation for Brain Biopsy—A Single Center Cohort Study
por: Vychopen, Martin, et al.
Publicado: (2022)

Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming
por: Lai, Xiaowei, et al.
Publicado: (2020)

Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds
por: Seo, Ji-Hye, et al.
Publicado: (2022)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bk8kfuc8qoilspivbf8pjth4ng